1. Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN‐003/MYX.1 single arm phase II trial. Issue 5 (12th April 2021) Authors: Venner, Christopher P.; LeBlanc, Richard; Sandhu, Irwindeep; White, Darrell; Belch, Andrew R.; Reece, Donna E.; Chen, Christine; Dolan, Sean; Lalancette, Marc; Louzada, Martha; Kew, Andrea; McCurdy, Arleigh; Monteith, Bethany; Reiman, Tony; McDonald, Gail; Sherry, Max; Gul, Engin; Chen, Bingshu E... Journal: American journal of hematology Issue: Volume 96:Issue 5(2021) Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma. (23rd June 2021) Authors: Monteith, Bethany E.; Venner, Christopher P.; Cheung, Matthew C.; Pater, Joe; Shepherd, Lois; Richardson, Harriet; Reece, Donna; Gul, Engin; Lalancette, Marc; Castonguay, Vincent; Kukreti, Vishal; Tiedemann, Rodger; Phua, Chai; Bhella, Sita; Dudebout, Jill; Sherry, Max; Yen, Hope; Chen, Bingshu E... Journal: European journal of haematology Issue: Volume 107:Number 3(2021) Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results. Issue 2 (18th August 2022) Authors: Kennecke, Hagen F.; O'Callaghan, Chris J.; Loree, Jonathan M.; Moloo, Hussein; Auer, Rebecca; Jonker, Derek J.; Raval, Manoj; Musselman, Reilly; Ma, Grace; Caycedo-Marulanda, Antonio; Simianu, Vlad V.; Patel, Sunil; Pitre, Lacey D.; Helewa, Ramzi; Gordon, Vallerie L.; Neumann, Katerina; Nimeiri, ... Journal: Journal of clinical oncology Issue: Volume 41:Issue 2(2023) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗